• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 14 XT PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 14 XT PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Catalog Number F2015-020
Medical Device Problem Codes Leak/Splash (1354); Difficult to Advance (2920); Material Split, Cut or Torn (4008)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 07/19/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was received.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.Na.
 
Event or Problem Description
It was reported that the procedure was performed to treat a de novo lesion with chronic total occlusion in the heavily calcified, mildly tortuous, 100% stenosed right anterior tibial artery.After placement of the 1.5x20mm armada 14 xt percutaneous transluminal angioplasty (pta) catheter, the guide wire was exchanged for a hi torque winn 200t, 300cm guide wire.During advancement, the guide wire met resistance negotiating the natural curve of the proximal anterior tibial artery while pushing through the armada catheter and punctured the catheter.Although the catheter was not inflated at any time, blood was observed in the inflation lumen and the hub.New devices were used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was returned.Visual analysis was performed.The reported leak and tear/puncture were confirmed.The difficulty advancing was not tested due to the condition of the device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation determined that the reported difficulties were likely due to case related circumstances.The resistance, tear in shaft and leak were likely the result of challenging anatomical conditions.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 14 XT PTA CATHETER
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8880145
Report Number2024168-2019-10708
Device Sequence Number11314202
Product Code LOX
UDI-Device Identifier08717648182884
UDI-Public08717648182884
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K121352
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2022
Device Catalogue NumberF2015-020
Device Lot Number90422G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/02/2019
Initial Date Received by Manufacturer 07/19/2019
Supplement Date Received by Manufacturer09/30/2019
Initial Report FDA Received Date08/09/2019
Supplement Report FDA Received Date10/14/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age87 YR
Patient Weight75
-
-